United States

Profile: Magforce AG (MF6G.F)

MF6G.F on Frankfurt Stock Exchange

21 Sep 2017
Change (% chg)

€0.04 (+0.49%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.

Company Address

Magforce AG

Max-Planck-Strasse 3
BERLIN     12489
P: +4930.3083800
F: +4930.30838099

Company Web Links